Advisory Board Member

Erik has been active in clinical development of pharmaceuticals in positions of increasing responsibility for more than 20 years. He has been responsible for clinical trials, trial teams, CROs, vendors, investigative sites and budgets in Africa, Asia, Europe, Russia and North and South America within more therapeutic areas, including oncology, CNS and vaccines.

Currently, Erik heads an European Clinical Operations group managing clinical trials for a broad range of sponsors. He holds a master’s degree in pharmacy from the University of Copenhagen, with specialisation in clinical pharmacy from Denmark and the US, and a bachelor’s degree in business administration from Copenhagen Business School.